Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

IMUX stock hub

Immunic, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IMUXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

158.2M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

IMUX

In the news

Latest news · IMUX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-1,653.1

P25 -105.6P50 -46.5P75 -3.1

ROIC-967.5

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IMUX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

175

Groups with data

Currency

USD

Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001280776
Company name	Immunic, Inc.
Country	United States
Country code	US
Cusip	4525EP200
Employees	92
Employees Change	1%
Employees Change Percent	1.1
Enterprise value	$143.3M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US4525EP2001
Last refreshed	2026-05-10
Market cap	$158.2M
Market cap category	Micro-Cap
Price	$11.63
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	IMUX
Website	https://imux.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-61.44%
FCF yield	-54.35%

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-97.2M
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Profit Per Employee	$-1.1M
ROA	-198.8
Roa5y	-93.3
ROCE	1,572.2
ROE	-1,653.1
Roe5y	-474.8
ROIC	-967.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	18.05%
Cagr3y	-11.18%
Cagr5y	-38.27%
EPS Growth Quarters	1
EPS Growth Years	4
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$24.1M
Cash	$15.5M
Current Assets	$22.9M
Current Liabilities	$30.6M
Debt	$577,000
Equity	$-6.7M
Liabilities	$30.7M
Long Term Assets	$1.2M
Long Term Liabilities	$107,000
Net Cash	$14.9M
Net Cash By Market Cap	$9.42
Net Cash Growth	-57%
Tangible Book Value	$-6.7M
Tangible Book Value Per Share	$-0.55
WACC	10.85

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.75
Net Working Capital	$-22.8M
Quick ratio	0.64
Working Capital	$-7.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-55.42%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	18.04%
200-day SMA	8.67
3Y total return	-29.94%
50-day SMA	11.24
50-day SMA vs 200-day SMA	50over200
5Y total return	-91.03%
All Time High	289.9
All Time High Change	-95.99%
All Time High Date	2019-04-15
All Time Low	5.06
All Time Low Change	129.75%
All Time Low Date	2025-12-30
ATR	1.05
Beta	1.21
Beta1y	-0.09
Beta2y	0.81
Ch YTD	117.9
High	12.09
High52	15.1
High52 Date	2026-03-12
High52ch	-22.98%
Low	11.25
Low52	5.06
Low52 Date	2025-12-30
Low52ch	129.75%
Ma50ch	3.46%
Price vs 200-day SMA	34.09%
RSI	56.99
RSI Monthly	46.8
RSI Weekly	60.01
Sharpe ratio	0.57x
Sortino ratio	0.92
Total Return	-55.42%
Tr YTD	117.9
Tr1m	-2.27%
Tr1w	20.52%
Tr3m	87.58%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	6
Analyst Count Top	3
Analyst Price Target Top	$35
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.91
Operating Income	$-103.2M
Price target	$36
Price Target Change	$210
Price Target Change Top	$201

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	10,471,586%
Float Percent	77%
Shares Insiders	1.28%
Shares Institutions	38.42%
Shares Out	13,600,000
Shares Qo Q	0.22%
Shares Yo Y	55.42%
Short Float	79.53%
Short Ratio	4.05
Short Shares	61.23

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-94.8M
Average Volume	368,924.75x
Bv Per Share	-0.55
CAPEX	$-161,000
Ch1m	-2.27
Ch1w	20.52
Ch1y	18.04
Ch3m	87.58
Ch3y	-29.94
Ch5y	-91.03
Ch6m	61.84
Change	-1.02%
Change From Open	-0.09
Close	11.75
Days Gap	-0.94
Depreciation Amortization	168,000
Dollar Volume	2,571,276.7
Earnings Date	2026-05-14
Earnings Time	amc
EBIT	$-103.2M
EBITDA	$-103.1M
EPS	$-6.24
F Score	1
FCF	$-86M
FCF EV Yield	-60.01x
FCF Per Share	$-6.32
Financing CF	65,577,000
Fiscal Year End	December
Founded	2,016
Investing CF	-161,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-02-26
Last Report Date	2025-12-31
Last Split Date	2026-04-27
Last Split Type	Reverse
Last10k Filing Date	2026-02-26
Ma150	8.57
Ma150ch	35.64%
Ma20	10.35
Ma20ch	12.38%
Net CF	-20,185,000
Next Earnings Date	2026-05-22
Open	11.64
Optionable	Yes
Position In Range	45.24
Post Close	11.63
Postmarket Change Percent	-0.26
Postmarket Price	$11.6
Ppne	1,183,000
Price Date	2026-05-08
Relative Volume	0.6x
Share Based Comp	8,863,000
Tr6m	61.84%
Us State	New York
Volume	221,090

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does IMUX pay a dividend?

Capital-return profile for this ticker.

Performance

IMUX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns IMUX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+38.4%

Float: +77.0% of shares outstanding

Insider ownership

+1.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

IMUX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

57.0

Neutral momentum band

Price vs 200-day MA

+34.1%

50/200-day relationship not available

Beta (5Y)

1.21

More volatile than the market

Sharpe ratio

0.57

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IMUX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current IMUX stock rating?

Immunic, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full IMUX analysis?

The full report lives at /stocks/IMUX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for IMUX?

The latest report frames IMUX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the IMUX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.